You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 14, 2025

Virtus Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for VIRTUS

VIRTUS has twelve approved drugs.



Summary for Virtus
US Patents:0
Tradenames:6
Ingredients:6
NDAs:12

Drugs and US Patents for Virtus

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Exclusivity Expiration
Virtus Pharm ALBUTEROL SULFATE albuterol sulfate TABLET;ORAL 211397-002 Oct 26, 2018 AB RX No No ⤷  Try for Free ⤷  Try for Free
Virtus DIAZEPAM diazepam TABLET;ORAL 070463-001 Feb 25, 1986 DISCN No No ⤷  Try for Free ⤷  Try for Free
Virtus PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 086365-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try for Free ⤷  Try for Free
Virtus PROMETRIUM progesterone CAPSULE;ORAL 019781-003 Oct 15, 1999 DISCN No No ⤷  Try for Free ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Exclusivity Expiration
Showing 1 to 4 of 4 entries
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Pharmaceutical Competitive Landscape Analysis: Virtus – Market Position, Strengths & Strategic Insights

In the ever-evolving pharmaceutical industry, understanding the competitive landscape is crucial for companies to maintain their edge and drive growth. This analysis focuses on Virtus Pharmaceuticals, examining its market position, strengths, and strategic insights within the context of the broader pharmaceutical sector.

Virtus Pharmaceuticals: An Overview

Virtus Pharmaceuticals is a specialty pharmaceutical company that has carved out a unique niche in the industry. Founded in 2011 and headquartered in Langhorne, Pennsylvania, Virtus has positioned itself as a provider of distinctive generic pharmaceutical products[9].

Company Profile

Virtus Pharmaceuticals specializes in manufacturing medical food, supplements, and Rx-OTC products[9]. With an estimated annual revenue of $5.0-25 million and an employee count ranging from 25 to 100, Virtus operates as a private, independent company in the Health Care Equipment & Services sector[9].

Leadership and Approval

Under the leadership of CEO Vinod Melvani, Virtus has maintained a strong reputation within the industry. The company boasts an impressive CEO approval rating of 90/100, indicating high confidence in its leadership[9].

Market Position and Financial Performance

While Virtus Pharmaceuticals may not be among the largest players in the pharmaceutical industry, it has established a solid market position within its niche.

Revenue and Growth

As of the latest available data, Virtus Pharmaceuticals' estimated annual revenue stands at $2.4 million[1]. This figure, while modest compared to industry giants, represents a significant achievement for a specialty pharmaceutical company focusing on unique generic products.

Employee Metrics

Virtus Pharmaceuticals currently employs 24 individuals, with an estimated revenue per employee of $100,500[1]. However, it's worth noting that the company experienced a 35% decrease in employee count over the past year, which could indicate strategic restructuring or market challenges[1].

"Virtus Pharmaceuticals is a unique generic pharmaceutical company that caters to a wide variety of customers. The products that we market are unique and unavailable at most other companies."[1]

Competitive Advantages of Virtus Pharmaceuticals

Despite its relatively small size, Virtus Pharmaceuticals has several competitive advantages that set it apart in the pharmaceutical landscape.

Unique Product Portfolio

One of Virtus' key strengths lies in its distinctive product offerings. The company focuses on marketing products that are unique and often unavailable from other pharmaceutical companies[1]. This strategy allows Virtus to occupy specific market niches with less direct competition.

Regulatory Compliance

Virtus Pharmaceuticals emphasizes strict adherence to FDA guidelines and operating procedures[1]. This commitment to regulatory compliance not only ensures product quality but also builds trust with customers and partners.

Industry Experience

With over 100 years of combined experience in pharmaceutical sales and marketing, the Virtus team brings a wealth of knowledge and expertise to the table[1]. This deep understanding of the marketplace enables the company to navigate industry challenges effectively.

Diverse Customer Base

Virtus markets its products to a wide range of customers, including distributors, wholesalers, chains, and health systems[1]. This diversified customer base helps mitigate risks associated with reliance on a single market segment.

Product Variety

The company offers various dosage forms, including tablets, capsules, softgels, creams, and ointments[1]. This variety allows Virtus to cater to different patient needs and preferences.

Efficient Operations

Virtus Pharmaceuticals prides itself on efficient storage, shipping, receiving, and return processes for pharmaceuticals[1]. This operational efficiency can lead to cost savings and improved customer satisfaction.

Customer Service Focus

The company maintains a dedicated customer service team to handle existing pharmaceutical orders, ensuring smooth transactions and building long-term relationships with clients[1].

Competitive Landscape and Key Rivals

While Virtus Pharmaceuticals operates in a specialized niche, it still faces competition from various players in the pharmaceutical industry. Understanding these competitors is crucial for assessing Virtus' market position and potential growth opportunities.

Top Competitors

According to available data, Virtus Pharmaceuticals' top competitors include:

  1. Imaging Endpoints
  2. Southern Scripts
  3. Alfasigma USA
  4. US WorldMeds
  5. KCAS Bioanalytical and Biomarker Services[1]

Competitor Analysis

Let's take a closer look at how Virtus compares to its top competitors:

1. Imaging Endpoints

  • Revenue: $46.2 million
  • Employees: 230
  • Employee Growth: 5%

2. Southern Scripts

  • Revenue: $43.8 million
  • Employees: 218
  • Employee Growth: 21%

3. Alfasigma USA

  • Revenue: $57.1 million
  • Employees: 284
  • Employee Growth: 26%

4. US WorldMeds

  • Revenue: $24.5 million
  • Employees: 122
  • Employee Growth: 3%

5. KCAS Bioanalytical and Biomarker Services

  • Revenue: $52.9 million
  • Employees: 263
  • Employee Growth: 13%[1]

Compared to these competitors, Virtus Pharmaceuticals has a smaller revenue and employee base. However, its focus on unique generic products and efficient operations may allow it to compete effectively within its specific market segments.

Industry Trends and Challenges

The pharmaceutical industry is constantly evolving, presenting both opportunities and challenges for companies like Virtus Pharmaceuticals.

Generic Drug Market Growth

The global generic drug market continues to expand, driven by factors such as patent expirations of branded drugs, government initiatives to reduce healthcare costs, and increasing demand for affordable medications. This trend could benefit Virtus, given its focus on unique generic products.

Pricing Pressures

Generic drug manufacturers face ongoing pricing pressures due to increased competition and regulatory scrutiny. Virtus must navigate these challenges while maintaining profitability.

Regulatory Environment

The pharmaceutical industry operates under strict regulatory oversight. Virtus' commitment to FDA compliance positions it well, but staying abreast of evolving regulations remains crucial.

Technological Advancements

Innovations in drug development, manufacturing processes, and digital health technologies are reshaping the pharmaceutical landscape. Virtus must stay current with these advancements to remain competitive.

Strategic Insights and Future Outlook

Based on the analysis of Virtus Pharmaceuticals' market position and competitive landscape, several strategic insights emerge:

Leverage Unique Product Portfolio

Virtus should continue to focus on developing and marketing unique generic products that fill specific market gaps. This strategy can help the company maintain its competitive edge and potentially expand its market share.

Invest in Research and Development

To stay ahead in the rapidly evolving pharmaceutical industry, Virtus should consider increasing its investment in R&D. This could lead to the development of new products and innovative formulations, further differentiating the company from competitors.

Expand Market Reach

While Virtus already caters to a diverse customer base, there may be opportunities to expand into new geographic markets or healthcare segments. Exploring partnerships or strategic alliances could facilitate this expansion.

Enhance Operational Efficiency

Virtus should continue to focus on improving its operational efficiency, particularly in areas such as supply chain management and customer service. This can help the company maintain competitive pricing while ensuring high-quality products and services.

Embrace Digital Transformation

Investing in digital technologies could help Virtus streamline its operations, enhance customer experiences, and gain valuable market insights. This could include implementing advanced analytics, e-commerce platforms, or digital marketing strategies.

Key Takeaways

  • Virtus Pharmaceuticals has established a niche in the pharmaceutical industry by focusing on unique generic products.
  • The company's strengths include its distinctive product portfolio, regulatory compliance, industry experience, and efficient operations.
  • Virtus faces competition from larger pharmaceutical companies but differentiates itself through its specialized offerings.
  • The growing generic drug market presents opportunities for Virtus, but the company must navigate challenges such as pricing pressures and regulatory changes.
  • Strategic focus areas for Virtus include leveraging its unique product portfolio, investing in R&D, expanding market reach, enhancing operational efficiency, and embracing digital transformation.

FAQs

  1. Q: What sets Virtus Pharmaceuticals apart from other generic drug manufacturers? A: Virtus Pharmaceuticals distinguishes itself by focusing on unique generic products that are often unavailable from other companies, adhering strictly to FDA guidelines, and leveraging over 100 years of combined industry experience.

  2. Q: How does Virtus Pharmaceuticals' revenue compare to its main competitors? A: Virtus Pharmaceuticals' estimated annual revenue of $2.4 million is lower than its main competitors, such as Imaging Endpoints ($46.2 million) and Alfasigma USA ($57.1 million). However, Virtus operates in a specialized niche market.

  3. Q: What are the main challenges facing Virtus Pharmaceuticals in the current pharmaceutical landscape? A: Key challenges include pricing pressures in the generic drug market, navigating complex regulatory environments, keeping pace with technological advancements, and competing with larger pharmaceutical companies.

  4. Q: How can Virtus Pharmaceuticals leverage its strengths to grow in the future? A: Virtus can capitalize on its strengths by continuing to develop unique generic products, investing in R&D, expanding its market reach, enhancing operational efficiency, and embracing digital transformation to stay competitive.

  5. Q: What role does customer service play in Virtus Pharmaceuticals' business model? A: Customer service is a key focus for Virtus Pharmaceuticals. The company maintains a dedicated customer service team to handle existing pharmaceutical orders, which helps build long-term relationships with clients and ensure smooth transactions.

Sources cited: [1] https://growjo.com/company/Virtus_Pharmaceuticals [9] https://www.owler.com/company/virtusrx

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.